Eurocine Vaccines AB has today selected Biovian Oy, Turku, Finland, as the contract developer for the Company's vaccine candidate against chlamydia. Biovian, which is an internationally recognized contract developer and manufacturer with its own GMP ...
Eurocine Vaccine Corporation today announced that it has been approved to conduct phase I / II clinical studies on the immunose ™ FLU quadrivalent vaccine candidate